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We report here two new small-size peptides acting as modulators of the β-site APP cleaving enzyme 1 (BACE1) exosite.
15 Ac-YPYFDPL-NH2 and Ac-YPYDIPL-NH2 displayed a moderate but signiﬁcant inhibitory effect on BACE1. These
peptides were obtained from a molecular modeling study. By combining MD simulations with ab initio and DFT calcula-
tions, a simple and generally applicable procedure to evaluate the binding energies of small-size peptides interacting with
the exosite of the BACE1 is reported here. The structural aspects obtained for the different complexes were analyzed
providing a clear picture about the binding interactions of these peptides. These interactions have been investigated
20 within the framework of the density functional theory and the quantum theory of atoms in molecules using a reduced
model. Although the approach used here was traditionally applied to the study of noncovalent interactions in small mole-
cules complexes in gas phase, we show, through in this work, that this methodology is also a very powerful tool for the
study of biomolecular complexes, providing a very detailed description of the binding event of peptides modulators at
the exosite of BACE1.
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1. Introduction
Alzheimer’s disease (AD) is the most common form of
dementia affecting 6–10% of people over the age of 65
(Clippingdale, Wade, & Barrow, 2001). Several possible
30 molecular mechanisms may initiate AD. However, con-
siderable genetic and biochemical evidence suggests that
the amyloid β-peptide (Aβ) misfolding oligomerization
and accumulation in the brain is the primary cause of the
neuronal dysfunction (Hardy & Selkoe, 2002).
35 The most widely accepted theory regarding the etiol-
ogy of AD is known as the “amyloid hypothesis” which
features the Aβ as the central pathological agent. This
hypothesis posits that pathology initiates because of an
imbalance in Aβ production and/or clearance, which may
40 result from altered expression or processing of amyloid
precursor protein (APP) or changes in Aβ metabolism
(Hardy & Selkoe, 2002). Development of therapies that
reduce amyloidogenic processing holds great promise but
has not yet proven successful clinically (Cummings,
45 2010). The aspartyl protease β-site APP cleaving enzyme
1 (BACE1) is the primary β-secretase in the brain,
making it a prime candidate for AD therapeutics. Many
potent BACE1 inhibitors (INHs) have been described,
but only recently some have been reported that are able
50to cross the blood–brain barrier in sufﬁcient quantities to
produce the biological effect (Varghese, 2010). In fact,
most of the aspartyl protease INHs in current clinical use
today are peptidomimetics that target the catalytic active
site of the enzyme. While these drugs have demonstrated
55usefulness for treating systemic viral infections, their
meager ability to cross the blood–brain barrier may
prove to be an obstacle to the use of such compounds
for treating diseases of the central nervous system, such
as AD.
60In addition to the active site, BACE1 contains an
additional binding pocket, termed exosite, which engages
substrates in the vicinity of the active site (Gutierrez,
Enriz, & Baldoni, 2010; Kornacker et al., 2005). Previ-
ously, we reported that this binding pocket can contribute
65signiﬁcantly to the stabilization of the enzyme–substrate
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binary complex by providing important structural deter-
minants of interaction (Gutierrez et al., 2010). Addition-
ally, this exosite can act as allosteric regulator of the
enzyme activity, causing an augmentation or diminution
5 of the enzyme’s catalytic reactivity. Kornacker et al.
reported that some small peptides bind to the exosite of
BACE1 in a manner that is unaffected by active site
ligand occupancy (Kornacker et al., 2005). Peptides that
bind in this exosite are able to inhibit the ability of
10 BACE1 to hydrolyze its natural protein substrate, APP. It
must be pointed out that the effect of these peptides is at
the exosite of the enzyme and not in the catalytic site;
therefore, we can expect a modulating effect and not
necessarily a potent inhibitory activity. Having clariﬁed
15 this concept, from now we will use indistinctly the terms
modulator or inhibitor.
Experimental evidences showed that it is possible to
inhibit the catalytic activity of BACE1 by targeting its
exosite (Atwal et al., 2011; Zhou et al., 2011). These
20 authors have designed a bispeciﬁc mAb; one arm com-
prising a low-afﬁnity anti-transferrin Fab fragment (anti-
TfR), and the other arm comprising the high-afﬁnity
anti-BACE1 Fab fragment (anti-BACE1). They showed
by X-ray crystallography that these antibodies inhibit
25 BACE1 activity by binding the BACE1-exosite.
Our research group reported the exact location of the
BACE1-exosite using a blind docking study demonstrat-
ing the utility of this technique (Gutierrez et al., 2010).
More recently, we have reported the structural and ther-
30 modynamic characteristics of this exosite by utilizing the
technique of alanine scanning (Gutiérrez, Andujar, Enriz,
& Baldoni, 2013) Once we possess such information, the
main objective of the present work is to obtain new pep-
tides modulators of the exosite of BACE1. To achieve
35 this objective, we performed in the ﬁrst step a molecular
modeling study on a series of peptides previously
reported by Kornaker et al. with inhibitory properties on
the exosite of BACE1. In this study, we combined MD
simulations with quantum mechanics (semiempirical and
40 DFT) calculations. In order to better evaluate the molec-
ular interactions (MI) between the peptides and the
BACE1-exosite, a quantum theory of atoms in molecules
(QTAIM) analysis of the different complexes was also
carried out. The principal goal of such study was to per-
45 form a comparative analysis among the stabilizing and
destabilizing interactions involved in the different com-
plexes in order to obtain a structure–afﬁnity relationship.
A reasonable correlation between
P
qðrÞ obtained from
QTAIM calculations and experimental data (Kornacker
50 et al., 2005) was obtained for the complexes studied
here. On the basis of this crucial information in the sec-
ond step of our study, we have designed, synthesized,
and tested new structurally related peptides that possess
the desired modulatory activity.
552. Materials and methods
2.1. Experimental section
2.1.1. Solid-phase peptide synthesis of Ac-YPYFDPL-
NH2 and Ac-YPYDIPL-NH2
The peptides were synthesized on an Fmoc-Rink Amide
60AM resin (.3 mmol g−1), on a .3 mmol scale with a stan-
dard Fmoc-chemistry, applying DCC/HOBt as coupling
reagents in a mixture of DCM/DMF. The efﬁciency of
the couplings was monitored with ninhydrin test. The
peptides were acetylated with a mixture containing 10%
65(v/v) acetic acid anhydride and 5% (v/v) DIEA in DCM.
The peptides were cleaved from the resin with a mix-
ture of TFA/H2O/TIS (95:2.5:2.5 volume ratio) at 0 °C for
.25 h, and at room temperature for 2 h. The TFA was
removed in vacuo. The peptides were dissolved in 40%
70acetonitrile in water and lyophilized. Crude peptides were
puriﬁed by RP-HPLC on a Phenomenex Luna C18 column
(250 × 21.20 mm, pore size: 100 Å, particle diameter:
10 μm, ﬂow rate: 3 ml/min). The solvent system consisted
of .1% TFA in water (A), and .1% TFA in 80% acetonitrile
75(B). Purity of the peptides was checked by analytical RP-
HPLC equipped with a Phenomenex Luna C18 column
(250 × 4.6 mm, pore size: 100 Å, particle diameter: 5 μm,
ﬂow rate: 1.2 ml/min) and by ESI-MS in a positive ion
mode. The HPLC and MS results for both peptides are
80shown in supplementary material (Figures 1S and 2S).
2.1.2. BACE1 ﬂuorescence resonance energy transfer
(FRET) assay
The BACE1 FRET assay kit was purchased from Sigma
(Catalog Number CS0010). BACE1 activity assays were
85carried out following the protocol of manufacturer. The
BACE1 assay was carried out on Perkin Elmer lumines-
cence spectrometer LS50B, excitation 320 nm (slit
12 nm) and emission 405 nm (slit 12 nm).
2.2. Molecular modeling
90Calculations were carried out in three steps. In the ﬁrst
step, we performed preliminary molecular dynamic simu-
lations of BACE1 with the peptides listed in Table 1. In
the second step, reduced model systems were optimized
using quantum mechanics calculations. Semiempirical
95(PM6 and PM6-COSMOS) combined with B3LYP (6-
31G(d)) calculations were employed in such optimiza-
tions. Finally, the ten complexes obtained in the previous
steps were further analyzed from a QTAIM study.
2.2.1. System setup
100The starting geometry used in this work was the called
as “C4” in our previous work in which we reported the
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structural characteristics of the exosite of BACE1
(Gutierrez et al., 2010). In this study, we used the same
inhibitor (compound 8) as template; thus the different
5 ligands shown in Table 1 were constructed by adding or
removing amino acids from such starting structure.
2.2.2. Molecular dynamics simulations
To relax the binding complexes, thirty-nanosecond MD
simulations were performed for the different BACE1-
10 inhibitor (BACE1-INH) systems using Amber software
(Case et al., 2012). The protein force ﬁeld was taken
from ff99SBildn (Lindorff-Larsen et al., 2010).
Each complex BACE1–INH was soaked in a trun-
cated octahedral periodic box of TIP3P water molecules
15 (Jorgensen, Chandrasekhar, Madura, Impey, & Klein,
1983). The distance between the edges of the water box
and the closest atom of the solutes was at least 10 Å.
Na + ions were added to neutralize the systems charge.
The entire system was subject to energy minimization
20 in two stages to remove bad contacts between the com-
plex and the solvents molecules. Firstly, the water
molecules were minimized by holding the solute ﬁxed
with harmonic constraints of 100 kcal/mol Å2 strength.
Secondly, conjugate gradient energy minimizations were
25 performed repeatedly four times using positional
restraints to all heavy atoms of the receptor with 15,
10, 5, and 0 kcal/mol Å2. The system was then heated
from 0 to 300 K in 300 ps and equilibrated at 300 K
for another 200 ps. After minimization and heating,
30 three independent simulations with length to 10 ns were
performed at a constant temperature of 300 K and a
constant pressure of 1 atm. During minimization and
MD simulations, particle mesh Ewald method (Essmann
et al., 1995) was employed to treat the long-range elec-
35 trostatic interactions in a periodic boundary condition.
Hydrogen stretching motions were removed using
SHAKE algorithm (Ryckaert, Ciccotti, & Berendsen,
1977) allowing an integration time step of 2 fs and the
nonbonded cutoff distance was 8.0 Å. The only differ-
40ence between replicates was in the initial velocity
assignments at the start of the dynamics.
2.2.3. Binding energy calculations
The MM-GBSA protocol was applied to each MD trajec-
tory in order to calculate the relative binding energies of
45the BACE1–INH complexes. The MM-GBSA method
was used in a hierarchical strategy, and the details of this
method have been presented elsewhere (Kollman et al.,
2000). This protocol was applied to 1000 equidistant
snapshots extracted from the last 5.0 ns of each replicate
50and was used within the one-trajectory approximation.
Brieﬂy, the binding free energy (ΔGbind) resulting from
the formation of a RL complex between a ligand (L) and
a receptor (R) is calculated as
DGbind ¼ DEMM þ DGsolTDS (1)
55
DEMM ¼ DEinternal þ DEelectrostatic þ DEvdw (2)
DGsol ¼ DGGB þ DGSA (3)
60where ΔEMM, ΔGsol, and −TΔS are the changes in the
gas-phase MM energy, the solvation free energy, and the
conformational entropy upon binding, respectively.
ΔEMM includes ΔEinternal (bond, angle, and dihedral ener-
gies), ΔEelectrostatic (electrostatic), and ΔEvdw (van der
65Waals) energies. ΔGsolv is the sum of electrostatic solva-
tion energy (polar contribution), ΔGGB, and the non-elec-
trostatic solvation component (nonpolar contribution),
ΔGSA. Polar contribution is calculated using the GB
model, while the nonpolar energy is estimated by solvent
70accessible surface area. The conformational entropy
change −TΔS is usually computed by normal-mode anal-
ysis, but in this study the entropy contributions were not
calculated due to the computational cost involved in such
calculations.
Table 1. Sequence for exosite-binding peptides of BACE1.
INH Sequencea
1 Ac-Pro10-Leu11-Pro12-NH2
2 Ac-Ile9-Pro10-Leu11-Pro12-NH2
3 Ac-Tyr5-Pro6-Tyr7-Phe8-Ile9-NH2
4 Ac-Tyr5-Pro6-Tyr7-Phe8-Ile9-Pro10-NH2
5 Ac-Tyr5-Pro6-Tyr7-Phe8-Ile9-Pro10-Leu11-Pro12-NH2
6 Ac-Thr4-Tyr5-Pro6-Tyr7-Phe8-Ile9-Pro10-Leu11-Pro12-NH2
7 Ac-Thr3-Thr4-Tyr5-Pro6-Tyr7-Phe8-Ile9-Pro10-Leu11-Pro12-NH2
8 Ac-Tyr5-Pro6-Tyr7-Phe8-Ile9-Pro10-Leu11-NH2
9 Ac-Tyr5-Pro6-Tyr7-Phe8-Asp9-Pro10-Leu11-NH2
10 Ac-Tyr5-Pro6-Tyr7-Asp8-Ile9-Pro10-Leu11-NH2
aResidue numbering was taken from reference Kornacker et al. (2005).
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5 2.2.4. Constructing the reduced models for the binding
site
The use of model systems to calculate and simulate MI
is necessary since the INHs interacting at the exosite of
BACE1 constitute a molecular system, too large for
10 accurate Quantum Mechanic Molecular Orbital calcula-
tions, and the number of peptides to be screened is large
as well. Moreover, a model system representing the bind-
ing pocket of BACE1-exosite may be desirable in order
to evaluate the ability of the ligands to interact with this
15 exosite. Using a model, complexities due to the rest of
the BACE1 enzyme are avoided. The questions which
arise are as follows: how can we select only those amino
acids involved in the interactions forming the different
BACE1–INH complexes? To acquire a more detailed
20 insight into the mechanisms driving the bindings of
INHs to the exosite of BACE1, the structure–afﬁnity
relationship was analyzed. The information obtained
from these calculations is very important for quantitative
analyses and is highly useful to the understanding of the
25 binding mechanism. Figure 1 shows the inhibitor–residue
interaction spectra calculated by the free energy decom-
position, which suggests that the interaction spectra of
INHs 1–8 with the exosite of BACE1 are closely related
and reﬂect their similar binding modes.
30 From these results, we considered prudently to
include in the reduced model not just those amino acids
involved in the most relevant MI displayed in the differ-
ent spectra, but also all the residues involved in stabiliz-
ing and destabilizing interactions showing nonnegligible
35 contribution in the per residue energy decomposition
spectra. Thus, residues Glu163, Glu255, Lys256,
Phe257, Pro258, Asp259, Gly260, Phe261, Trp262,
Leu263, Gly264, Glu265, Gln266, Leu267, Val268,
Cys269, Trp270, Gln271, Ala272, Gly273, Thr274,
40 Asp311, Val312, Ala313, Thr314, Ser315, Gln316,
Asp317, Asp318, Cys319, Tyr320, Lys321, and Phe322
were included in the reduced model for the exosite of
BACE1, and, therefore, a ﬁnal number of 33 amino
acids were included in our model.
45 2.2.5. Quantum mechanics calculations
Considering the 33 amino acids selected on the basis of
the per-residue energy decomposition spectra plus the
residues from the inhibitor, the number of atoms of the
reduced model rises up to 718 in BACE1–INH 8 com-
50 plex. The size of the molecular system and the complex-
ity of the structures under investigation restricted the
choice of the quantum mechanical method to be used.
Consequently, geometrical optimizations for the different
complexes were carried out at semiempirical level (PM6
55 and PM6-COSMOS), whereas single point calculation at
DFT (B3LYP/6-31G(d) levels were performed in order
to obtain the energy values of the complexes under
study.
The binding energy of the complexes at quantum
60mechanical level was calculated using the supermolecular
approach, that is, calculated by subtracting the energies
of the isolated compounds (in the complex geometry)
from the energy of BACE1–INH complex.
BEQM ¼ EExoþINH  EExo þ EINHð Þ (4)
65where BEQM is the binding energy at quantum mechani-
cal level, EExo + INH the exosite–inhibitor complex
energy, EExo the energy of the reduced receptor model
(exosite), and EINH the energy of the inhibitor.
70The PM6 and PM6-COSMOS calculations were car-
ried out using MOPAC program (James Stewart, 2012),
whereas DFT calculations were performed by using
Gaussian 09 software (Frisch et al., 2009).
2.2.6. Topological study of the electron charge density
75distribution
For the study of MI between peptides 1-8 and the
BACE1-exosite, the molecular complexes obtained for
our “reduced model system” were used as input for the
calculation of the charge density. The complexity of the
80system under study restricts the choice of the quantum
mechanical method to be used. Therefore, single point
calculations were performed with the Gaussian 09 pro-
gram package employing the B3LYP hybrid functional
and 6-31G(d) as a basis set. This type of calculation has
85been used in recent works on the topology of the charge
density (ρ(r)) because it ensures a reasonable compromise
between the wave function quality required to obtain reli-
able values of the derivatives of ρ(r) and the computer
power available (Tosso et al., 2013). The topological
90properties of a scalar ﬁeld such as ρ(r) are summarized in
terms of their critical points, i.e., the points rc where
∇ρ(r) = 0. Critical points are classiﬁed according to their
type (ω, σ) by stating their rank, ω and signature, σ. The
rank is equal to the number of nonzero eigenvalues of
95the Hessian matrix of ρ(r) at (rc), while the signature is
the algebraic sum of the signs of the eigenvalues of this
matrix. Critical points of (3, −1) and (3, +1) type describe
saddle points, while the (3, −3) is the maximum and (3,
+3) is the minimum in the ﬁeld. Among these critical
100points, the (3, −1) or bond critical points (BCPs) are the
most relevant ones since they are found between any two
atoms linked by a chemical bond. The determination of
all the bond BCPs and the corresponding bond paths that
connect these points with the bonded nuclei, the calcula-
105tions of local topological properties of ρ(r) at the BCPs,
as well as, the display of molecular graphs were
performed with the AIMAll software (Keith, 2012).
4 L.J. Gutierrez et al.
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Figure 1. Spectra of residue interactions obtained for the complexes Inhibitor-BACE1: (a) 1, (b) 2, (c) 3, (d) 4, (e) 5, (f ) 6, (g) 7,
and (h) 8 according to the MM-GBSA method.
Note: The x-axis denotes the residue number of BACE1 and the y-axis denotes the interaction energy between the inhibitor and speci-
ﬁc residues.
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It should be noted that QTAIM calculations were
carried out using a higher level of computations than that
5 used for geometrical optimization. Thus, from the point
of view of the DFT level applied, the PM6-minimized
structure is a “random conformation,” and some espe-
cially weaker bonds cannot be correctly identiﬁed. Cer-
tainly the ideal situation would be to perform structure
10 minimizations at the same computational level than the
QTAIM analysis. However, due to the computational
cost of performing an energy minimization at the DFT
level, it would be necessary to reduce the size of the
model system, losing the additive part of the intermolec-
15 ular interactions (cooperative effects). Therefore, we have
preferred to resign some quality and build a reduced
model as representative as possible of the active site.
The argument is that the QTAIM methodology is rela-
tively insensitive to the method of calculation (Castillo
20 & Boyd, 2005; Jabłoński & Palusiak, 2010; Matta,
2010). Therefore, the topological elements which are pre-
sent at the higher level wave function, though more
accurately computed will be essentially the same than in
the lower level wave function, provided that the geome-
25 try is the same.
3. Results and discussion
3.1. Equilibrium of the molecular dynamics
simulation
The root-mean-square deviation (RMSD) of each snap-
30 shot relative to the initial structure was calculated to
monitor the stability of each trajectory. The RMSD
obtained for the backbone atoms for each component of
complex (BACE1 and INH chains) of all the trajectories
remains constant during the last 5 ns of MD simulation,
35 indicating the stability of the studied complexes (see Fig-
ures 3S and 4S and Table 1S in supplementary material).
The trajectory of last 5 ns of each replicate was taken for
the structural and energetic analysis.
3.2. Binding free energy
40By the MM-GBSA analysis (Kollman et al., 2000), the
total free energy of binding might be separated into elec-
trostatic, van der Waals, and solute–solvent interactions,
thus gaining additional insights into the physics of the
BACE1–INH association process. The binding free
45energy and the energy components of the complexes are
summarized in Table 2. According to Table 2, electro-
static (ΔEele), van der Waals (ΔEvdw), and terms of non-
polar solvation energies (ΔGNP) provide the major
favorable contributions to the INH binding, whereas
50polar solvation energies (ΔGGB) impair to the INH bind-
ing. Further insight into the forces involved in BACE1–
INH complex formation can be obtained by analyzing
the electrostatic (ΔGele,tot) and nonelectrostatic (ΔGNP,tot)
contributions (Table 2). Indeed, from Table 2, we can
55appreciate that, despite the favorable electrostatic ener-
gies in the gas phase (ΔEele), the contributions of polar
solvation energies to binding (ΔGGB) are unfavorable for
all the complexes studied here, and the ΔGele,tot (the sum
of ΔEele and ΔGGB) does not favor the binding. Table 2
60also suggests that the net result of nonelectrostatic inter-
action (ΔGNP,tot, the sum of ΔEvdw and ΔGNP) is favor-
able for the formation of all the complexes. It should be
noted that this behavior has been proposed previously as
a general trend for noncovalent ligand–receptor associa-
65tions (Chen, Yang, Yi, Shi, & Zhang, 2009). From the
above results, we can conclude that the binding free
energies obtained for these complexes are driven by
more favorable nonpolar interactions rather than by elec-
trostatic ones.
70Next, the binding energies (BE = ΔGbind) obtained
for the different complexes were evaluated. The correla-
tion coefﬁcient obtained between the experimental per-
centages of inhibition vs. the binding energies calculated
from MM-GBSA was acceptable giving a value of
75r = −.86 (Figure 2(a)). On the basis of the binding ener-
gies obtained from our MD simulations, a good inhibitor
Table 2. Binding free energies computed by the MM-GBSA method (kcal/mol).
INH ΔEele ΔEvdw ΔGGB ΔGNP ΔGele,tot ΔGNP,tot ΔGBind %inhibition
a
1 −9.16 −22.36 20.49 −3.49 11.33 −25.85 −14.51 2.50
2 −8.18 −25.57 22.42 −4.76 14.24 −30.34 −16.09 2.50
3 −6.99 −42.66 30.12 −6.50 23.13 −49.16 −26.03 27.00
4 −40.59 −43.77 55.56 −6.35 14.97 −50.13 −35.16 37.00
5 −29.79 −53.77 57.05 −7.38 27.26 −61.15 −33.89 65.00
6 −58.33 −57.56 80.27 −8.14 21.93 −65.70 −43.76 67.00
7 −29.75 −64.26 57.66 −8.38 27.91 −72.64 −44.73 70.00
8 −3.07 −46.29 26.38 −6.76 23.30 −53.05 −29.75 71.00
9 −130.71 −39.58 156.68 −5.90 25.97 −33.68 −19.51 20.70b
10 −92.71 −52.53 119.28 −7.76 26.27 −44.77 −33.72 33.10b
a%inhibition was taken from reference Kornacker et al. (2005).
b%inhibition obtained from ours experimental results.
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can be differentiated from a very weak inhibitor
(−44.73 kcal/mol for compound 7 vs. −14.51 kcal/mol
for compound 1), but peptides with similar binding
5 afﬁnities cannot be easily differentiated. It is interesting
to note that compound 8 possesses the strongest inhibi-
tory effect; however, it has a relatively high BE
(−29.75 kcal/mol).
It should be noted that MD simulations might neglect
10 or poorly approximate terms that might be playing deter-
minant roles such as lone pair directionality in hydrogen
bonds, explicit π–π stacking polarization effects, hydro-
gen bonding networks, induced ﬁt, and conformational
entropy. Thus, we cannot expect to obtain clear differ-
15 ences between compounds possessing relatively similar
binding energies. At this stage of our work, we consider
the trend predicted by the MD simulations as indicative
and certainly interesting for an exploratory analysis, but
on the other hand, the approximations involved in this
20 approach compel us to go beyond to the classical treat-
ment of the interactions in order to conﬁrm our results.
Thus, in the next step, the reduced model systems were
optimized using the PM6, PM6-COSMOS semiempirical
methods, combined with DFT single point calculations.
253.3. Quantum mechanics calculations
The starting geometries for each complex were obtained
from the coordinates of the conformations displaying the
lowest potential energies during the simulations. PM6
optimizations were performed considering all amino
30acids (included in the reduced model, see methods of
calculations section). Next, in order to consider the sol-
vent effects, PM6-COSMOS optimizations were carried
out for the different complexes. Finally, DFT (B3YP/6-
31G(d)) single point calculation were carried out for
35each complex optimized from PM6 computations.
The RMSD data for the results obtained from PM6
and PM6-COSMOS are summarized in Table 3. From
these results, it is clear that the inclusion of the COSMO
continuum solvent model causes no geometry changes
40from the results generated by PM6 (RMSD < 1.5 Å), at
least for the complexes under study.
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Figure 2. Correlations obtained between the experimental percentages of inhibition vs. the binding energies calculated from (a)
MM-GBSA, (b) PM6 (light blue) and PM6-COSMOS (red), (c) B3LYP/6–31G(d), and (d) −log (
P
qðrÞ) calculations.
Note: It should be noted that the values of
P
qðrÞ have been plotted as −log in order to obtain a negative slope for comparative pur-
poses.
BACE1 exosite-inhibitors 7
TBSD 1145143 CE: PS QA: CS
8 February 2016 Initial
Once the BE of the different complexes were obtained
from the theoretical calculations (see Table 2S), we calcu-
late the different correlations between the theoretical cal-
5 culations and the experimental data (percentage of
inhibition) reported in reference (Kornacker et al., 2005).
Figure 2(b) and (c) gives a graphical representation
of the BE obtained from PM6 and DFT (B3LYP/6-31G
(d)) calculations vs. the experimental data. The ﬁgure
10 displays the following correlation coefﬁcients r = −.92,
−.87, and −.90, using PM6, PM6-COSMOS, and
B3LYP/6-31G(d)) calculations, respectively. These
results are satisfactory, considering the type of approxi-
mation used. From these results, it appears that the pre-
15 dicted ﬁrst-principle structure of the primary binding
pocket of BACE1-exosite leads to correct predictions of
the critical residues for binding INHs and gives relative
binding afﬁnities that correlate fairly well with the exper-
imental data. (Kornacker et al., 2005)
20 PM6 and DFT calculations performed here may not
properly consider the dispersion interactions. Fortunately,
in this case, it appears that such limitations are not sev-
ere enough to prevent us from obtaining our goals. Such
an assumption appears to be reasonable, considering the
25 signiﬁcant correlation obtained between the experimental
data and the theoretical calculations performed. However,
a kind of error-cancelation might have taken place, in
which case the approaches used in this study might be
operative only for the INHs analyzed here. An additional
30 validation and more calculations might be required to
extend these approaches to other compounds possessing
different structures. It is clear that more accurate calcula-
tions, such as QTAIM (Bader, 1985) analysis, are neces-
sary for a detailed description of these interactions. Such
35 calculations are presented in the next section.
3.4. Evaluating the MI for the different complexes
using QTAIM calculations
The topological analysis of the electron density distribu-
tion is widely applied to the characterization of the inter-
40 molecular interactions such as hydrogen and halogen
bonds in small gas-phase complexes (by means of the
QTAIM methodology). While this theory has tradition-
ally belonged to the ﬁeld of the theoretical chemists,
there are a number of recent works where it has been
45applied to the study of large biomolecular complexes
providing a very detailed description of the binding
event (Andujar et al., 2012; Angelina, Andujar, Tosso,
Enriz, & Peruchena, 2014; Párraga et al., 2013; Tosso
et al., 2013), therefore suggesting that this theory should
50be also adopted by the medicinal chemists and molecular
modelers. Accordingly, we performed a QTAIM descrip-
tion of the interactions on the reduced models of the
BACE1–INH complexes.
Previous to the QTAIM analysis, some comments
55about the selected peptides must be done. As can be seen
in Table 1, the small-size peptides selected (INH 1–8)
contain from 3 to 10 amino acids. The INH 7 represents
the entire peptide sequence (Ac-Thr3-Thr4-Tyr5-Pro6-
Tyr7-Phe8-Ile9-Pro10-Leu11-Pro12-NH2), and the other
60peptides lack some of the residues either in the Ac-termi-
nal or NH2-terminal fragment. By inspecting the inhibi-
tion data in Table 2, one might infer that the -Tyr5-Pro6-
sequence near to the Ac-terminal is essential for activity
because INHs 1 and 2 which lack these residues show
65negligible inhibitory activity against BACE1. Moreover,
INHs 3 and 4 which lack some residues from the NH2-
terminal fragment displayed just the half of the activity
of INHs 6 to 8. Pro10 and Leu11 residues are present in
the most active peptides, but they are not present in INH
703 and INH 4 (Pro10 and Leu11 in INH 3 and Leu11 in
INH 4) indicating that they are important for the modula-
tory activity as well. On the contrary, the absence of the
Thr3-Thr4 sequence/Pro12 residue from the C–/N– termi-
nus of INH 7, respectively, does not seem to affect the
75activity of the peptide since these terminal residues are
missing in INH 8 which is the most active compound in
this series.
Figure 5 shows the complexes obtained for INHs 1,
3, and 8 interacting with the BACE1-exosite, which are
80representative reduced models for poor, intermediate, and
good inhibitory activities, respectively (Figure 3).
Table 3. Structural difference between the optimized geome-
tries at PM6 and PM6-COSMOS level.
Complex Exosite + Ligand Exosite Ligand
1 1 1.02 .73
2 1.28 1.35 .62
3 .98 1.08 .67
4 1.07 1.15 .45
5 1.37 1.53 .46
6 .86 .97 .31
7 .8 .9 .32
8 .87 .97 .22
Notes: Root-mean-square deviation (RMSD) was calculated using
UCSF Chimera program.
Mon
o fo
r pr
int
colo
ur o
nlin
e
Figure 3. Spatial view of INHs 1, 3, and 8 in the exosite.
Note: Acetyl-terminal fragment (in red), NH2-terminal fragment
(in green), and the residues connecting both end fragments (in
yellow).
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It can be seen that the same residues of the inhibitor
(i.e., peptide fragments with the same color) bind
approximately to the same site in the BACE1-exosite, in
5 the three complexes. Thus, for example, the Ac-Tyr5-
Pro6- pattern (in orange) is interacting with residues from
the D-loop and F-loop in INHs 3 and 8. Therefore,
according to the previous observations, one might antici-
pate that the interactions of Ac-Tyr5-Pro6- end with
10 speciﬁc residues from these loops of the BACE1 would
be, at least partially, responsible for the modulatory
activity of these peptides.
At this point, it is interesting to estimate the strength
of the network of noncovalent interactions established
15 between the BACE1-exosite and the small peptides
selected. Starting with strong and moderate hydrogen
bonds, moving on to weaker polar interactions, and end-
ing with stacking and T-shape-like interactions, all of
them can be investigated within the framework of the
20 density functional theory and the QTAIM. Figure 2(d)
shows the correlation obtained between the experimental
percentages of inhibition values (%inhibition) vs. –log
(
P
qðrÞ) corresponding to the BCPs of inter- and intra-
molecular interactions in (BACE1-INH) complex.
25 The correlation coefﬁcient (r = −.95) is better than
those obtained from the BE calculated at PM6, PM6-
COSMOS, and DFT levels of theory (Figure 2(b) and
(c), respectively). Also, it should be noted that the corre-
lation obtained using the
P
qðrÞ is signiﬁcantly better
30 than that obtained from binding energies calculated from
MM-GBSA (Figure 2(a)). Moreover, the advantage of
the charge density sum over the BE is that it can be par-
titioned into several contributions that account for the
anchoring strength of each residue or sequence of resi-
35 dues into the INH. In addition, the standard deviation of
regression (S_reg) (also, namely residual standard devia-
tion or standard error of estimate) is an absolute measure
of dispersion of the Y values around the regression line,
and it can be used as a measure of the closeness of the
40 relationship between the variables. The smaller the
S_reg, closer the relationship; the higher the value of
S_reg, the more the actual observation tend to scatter
away from the regression line. In other words, the range
within which the S_reg must lie is as close to zero,
45 denoting an excellent relationship between the consid-
ered variables (Riu & Rius, 1996; William, Saul,
William, & Brian, 1986). The residual standard devia-
tions in Table 2S are of different units in the different
cases, and therefore cannot be compared directly. Thus,
50 the residual standard deviations were divided by the
slope of the ﬁtting line to be converted into the same
units (last row in Table 2S). It is interesting to note that
the S_reg obtained for the correlation using
P
qðrÞ dis-
played lower values of S_reg in comparison with those
55 obtained for the rest of correlations (see Table 2S in
supplementary material).
Accordingly, Figure 4 shows the sum of the charge
density values at the BCPs due to inter- and intra-inter-
actions in BACE1–INH complexes. It is partitioned into
60three contributions corresponding to the Ac-terminal
fragment (Ac-Thr3-Thr4-Tyr5-Pro6- in red color); the
NH2-terminal fragment (-Pro10-Leu11-Pro12- NH2 in
green), and the connector fragment (-Tyr7-Phe8-Ile9- in
yellow) between the two previous one. Note that one or
65more of these residues are absent in INHs other than
INH 7 (see Table 1).
Each category of the stacked bars indicates the
anchoring strength of a different fragment of the inhibi-
tor sequence, whereas the total height of the stacked bars
70indicates the binding strength of the entire peptide.
Since INHs 1 and 2 lack the Ac-terminal fragment
(Ac-Thr3-Thr4-Tyr5-Pro6-), which apparently is crucial
for modulatory activity, from now the discussion is cen-
tered in INHs 3 to 8.
753.5. Interactions due to the residues of the Ac-
terminal fragment
Figure 5 show the interactions of the INHs 3 to 8,
respectively, within the BACE1-exosite framework.
By the comparison of these ﬁgures, it can be seen
80that the peptide fragment Ac-Tyr5-Pro6- from INHs 4
(Figure 5(b)) as well as from INH 8 (Figure 5(f)) is
inserted between the backbones of the D- and F-loops.
In both complexes, the loops are farther apart from each
other than in the remaining complexes, and the acetyl
85group is interacting with the backbone of Ala272 and the
side chain of Glu317. In fact, the Cα–Cα separation dis-
tance between Gln271 (D-loop) and Asp317 (F-loop) is
remarkably larger when BACE1 is complexed with INH
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Figure 4. Charge density sum values at the BCPs (
P
qðrÞ),
due to inter and intra-molecular interactions in BACE1–INH
complexes.
Notes: These values were partitioned into three contributions:
(in red) due to interactions involving residues of the acetyl-ter-
minal fragment; (in green) involving residues of the NH2-termi-
nal fragment; and interactions involving residues connecting
both end fragments, in yellow.
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4 (6.956 Å) and INH 8 (8.055 Å) than with INH 3
5 (4.943 Å), INH 6 (4.901 Å), INH 7 (4.852 Å), and INH
5 (4.613 Å).
In complexes of BACE1 with INHs 7, 6, 5, and 3,
because the loops are closer together, the Ac-terminal
peptide fragment cannot be inserted between them but
10 instead, it just lies over F- and/or D-loops, interacting
with side chains of one or both loops.
Going back to Figure 4, it can be seen in this ﬁgure
that the acetyl end from INH 8 is more strongly
anchored into the exosite than the remaining peptides.
15 Besides INH 8, the second strongest anchored peptide is
INH 6. INHs 6 and 7 possess one and two additional
threonine residues in their Ac-terminal peptide fragment,
respectively, as compared with the other peptides. Thus,
instead of comparing the absolute anchoring strength of
20 the Ac-terminal peptide fragment in the different com-
plexes, it is more appropriate to measure how “efﬁcient”
is that binding to compute the anchoring strength per
number of atoms of the Ac-terminal peptide fragment.
Figure 6 shows the sum of the charge density values cor-
25responding to the interactions of the Ac-terminal peptide
fragment within the exosite divided its number of atoms,P
q=NA.
The
P
q  =NA ratio clearly shows that the Ac-ter-
minal peptide fragment from INHs 4 and 8 binds more
30efﬁciently to the exosite than in the same fragment from
INHs 3, 5, 6, and 7. This ﬁnding is in agreement with
the fact that in the ﬁrst two complexes, the acetyl end is
deeply inserted between the two loops interacting with
residues from both loops while in the last four com-
35plexes they just lie over the F- and/or D-loops.
The next question one may ask is what makes the
D- and F-loops be farther apart (and therefore the acetyl
end more inserted between both loops) in some com-
plexes than in the others. We explore this question in the
40next section.
3.6. Interactions of the connector fragment residues
Among the residues of the connector fragment of the
INHs, Tyr7 shows signiﬁcant differences in its interaction
pattern. By inspecting the complexes of BACE1 with the
45INHs (Figures 5(a)–(f )), it can be seen that in those
complexes where the D- and F-loops are closer together
(INHs 3, 5, and 6), the Tyr7 residue forms an H-bond
with the backbone carbonyl of Ala313 (i.e, (Ala313)
O∙∙∙H–O(Tyr7)), whereas in complexes where both loops
50are farther apart (INHs 4 and 8), the (Ala313)O∙∙∙H–O
(Tyr7) H-bond is absent and Tyr7 adopts a different con-
formation. Both situations can be compared in Figure 7.
Figure 7 shows the conformational changes experienced
by the backbone of the exosite after binding to INH 5
55(orange) wherein the (Ala313) O∙∙∙H–O (Tyr7) is present,
and also to INH 8 (green) wherein this H-bond is absent.
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Figure 5. Noncovalent interactions for the different complexes
(a) 3, (b) 4, (c) 5, (d) 6, (e) 7, and (f) 8.
Notes: The inhibitors are shown in blue and BACE1-exosite in
green. Also the elements of the topology of the electron density
are shown: yellow sticks represent the bond paths connecting
the nuclei and the red circles on them are the bond critical
points (3, −1 critical points). Due to the complexity of the
structure, only the most relevant interactions are shown in this
ﬁgure.
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Figure 6. Charge density sum values/number of atoms ratio
obtained for the intermolecular interactions for those inhibitors
possessing the Ac end fragment, (∑ρ/NA(Ac-TTYP)) in
selected BACE1–INH complexes.
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It is clearly seen in this ﬁgure that in complex
BACE1–INH 5 complex the interaction of Tyr7 with
Ala313 might help to keep the D- and F-loops close
5 together. On the contrary, in the complex of INH 8, the
NH2-terminal peptide fragment forms an H-bond with
Thr314 which might help to keep the F-loop and D-loop
more separated from each other.
But why (Ala313) O∙∙∙H–O (Tyr7) H-bond might be
10 formed in some complexes but not in the others? The
answer might lie in the sequence differences in the NH2-
terminal peptide fragment.
3.7. Interactions due to the residues of the NH2-
terminal fragment
15 By inspecting the complexes of BACE1 with the differ-
ent INHs (Figure 5(a)–(f)), it can be seen that in INHs 5
and 6 which have the entire sequence -Pro10-Leu11-
Pro12- in the NH2-terminal peptide fragment, the NH2
group is properly placed to act as H-donor in a bifur-
20 cated H-bond with the oxygen atom of Tyr7, enhancing
the (Ala313)O∙∙∙H–O(Tyr7) H-bond (see Figure 5(c) and
(d)). In the case of INH 7, even when it has the full
sequence at NH2-terminal peptide fragment, the (Ala313)
O∙∙∙H–O(Tyr7) H-bond is absent due to the formation of
25 an intramolecular H-bond with the backbone of Thr3.
On the other hand, INHs 4 and 8 lack the Leu11-
Pro12- and Pro12- residues in the NH2-terminal fragment,
respectively, and hence the terminal NH2 group is not
properly placed to stabilize the (Ala313) O∙∙∙H–O (Tyr7)
30 H-bond. As was discussed above, in the complex of
BACE1–INH 8, the carbonyl oxygen atom attached to
the terminal NH2 group forms a O∙∙∙H–O H-bond with
Thr314. This last interaction could not be established
without the previous disruption of the (Ala313) O∙∙∙H–O
35(Tyr7) H-bond because of the orientation of the Thr314
methyl group in BACE1–INH 8 complex, which pre-
vents the approach of Tyr7 over the Ala313 backbone
(see Figures 5(f) and 7). Moreover, in BACE1–INH 4
complex, the terminal NH2 group is forming a N–H∙∙∙π
40H-bond with Tyr7 (see Figure 5(a)).
It is worth noting that unlike BACE1–INH 8 com-
plex, in BACE1–INH 4 complex, the Ac-terminal pep-
tide fragment is not large enough to interact directly or
indirectly with F-loop residues. In BACE1-–INH 8 com-
45plex, the interaction of the NH2-terminal fragment with
Thr314 promotes the opening of the F-loop that helps the
Ac-terminal fragment to be more deeply inserted
between both loops and vice versa. In BACE1–INH 4
complex, the lack of these correlated displacements of
50the F-loop and the Ac-terminal fragment leads to the
weaker insertion of this fragment (and also the shorter
separation distance between both loops) and might
explain, at least in part, the poor % inhibition value (less
than half) showed by this peptide as compared to
55BACE1–INH 8 complex.
Finally, INH 3 would have no effect (neither enhancing
nor weakening) on the (Ala313) O∙∙∙H–O (Tyr7) H-bond
because this peptide has no other residues in its NH2-termi-
nal fragment that help to strengthen this H-bond.
603.8. Possible role of the peptides in the BACE1
modulation
An acceptable correlation between the sum of the charge
density values at the BCPs of the network of interactions
established in the BACE1–INH complex (
P
qðrÞ) and %
65inhibition values was found.
Since the presence of the Ac-terminal fragment is crit-
ical for modulatory activity, it is reasonable to think that
this peptide fragment might be involved in such confor-
mational changes. It has been shown that the conforma-
70tional change of the F-loop determines the opening or
closing of the cleft between the D- and F-loops. Among
both conformations, the open form seems to be the more
favorable for enzyme inhibition because it allows a more
efﬁcient binding of the Ac-terminal peptide fragment
75within the loops. INH 8, the peptide with the highest %
inhibition value, combines an open conformation of the
loops with one of the largest
P
qðrÞ values.
3.9. Designing new peptides with modulatory activity.
Experimental corroboration
80In order to design new peptides that might modulate the
exosite of BACE1, we take the peptide 8 as starting
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Figure 7. Backbone alignment for complexes BACE1–INH 8
(green) and BACE1–INH 5 (orange).
Notes: The ﬁgure shows the interactions behind the conforma-
tional changes of the D- and F-loops. Also the Cα–Cα separa-
tion distance (in Å) between Gln271 (D-loop) and Asp317 (F-
loop) is depicted for both complexes.
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structure. Both the results obtained from MM GBSA as
well as those obtained from the QTAIM studies were
considered for the design of these new peptides. MM-
5 GBSA results (Figure 8) allowed us to determine which
are the main amino acids involved in the main interac-
tions of the different complexes. In addition, the results
from QTAIM study (Figure 4) allowed us to quantify the
different interactions. These results suggest that the
10 amino acids that have the weakest interactions are Pro6,
Phe8, Ile9, and Pro 10, and therefore they are the amino
acid candidates to be replaced. Our simulations showed
that replacements on both Pro residues introduce pro-
found conformational changes, and therefore the pres-
15 ence of these two amino acids appears to be essential in
order that the compounds can adopt the biologically rele-
vant conformation. These results indicated that it would
not be advisable to replace the Pro residues for the
search of new INHs. Based on these results, we per-
20 formed various replacements on Phe8 and Ile9. Among
the simulated compounds, caught our attention mainly
was the two peptides (compounds 9 (Ac-Tyr5-Pro6-Tyr7-
Phe8-Asp9-Pro10-Leu11-NH2) and 10 (Ac-Tyr5-Pro6-
Tyr7-Asp8-Ile9-Pro10-Leu11-NH2)).
25 In the next step, we performed for peptides 9 and 10
all the same calculations that for the rest of the series in
order to compare the results. Our theoretical calculations
predict for peptides 9 and 10 inhibitory effects around
70 and 68%, respectively. Thus, we considered interest-
30 ing to synthesize and test the inhibitory activity of com-
pounds 9 and 10 for two reasons. The ﬁrst reason, which
is obvious, is to obtain new small-size peptides possess-
ing inhibitory activity against BACE1 acting at its exo-
site. The second reason is to corroborate experimentally
35 our theoretical predictions. The synthesis of compounds
9 and 10 was performed as was described in the experi-
mental section.
Our experimental measurements indicated that com-
pounds 9 and 10 possess % inhibition values of 20.7 and
4033.1 at 10 μM, respectively. It should be noted that the
inhibitory effects obtained for compounds 9 and 10 are
lower than those reported for peptide 8; however, these
new peptides displayed a signiﬁcant modulatory activity
against the exosite of BACE1. Although the experimen-
45tal results are somewhat different to those predicted by
the theoretical simulations, considering the different
experimental conditions, such results are very encourag-
ing. It is evident that the inhibitory effects of peptides 9
and 10 are less than those predicted by molecular model-
50ing; however, at least qualitatively, these theoretical cal-
culations indicate that peptides could have modulatory
effects. This result is a support for the molecular model-
ing studies performed here to assist the design of new
modulating agents acting on the exosite of BACE1.
55Finally, a question which might arise is about the
possible bioavailability of the designed small-size pep-
tides in body/brain. In order to obtain more information
on the physical–chemical characteristics of these pep-
tides, we have calculated their clog P. Clog P values are
60−.002, 9 for peptide 9 and −1.19 for peptide 10. Such
values indicate that these peptides tend to have low
lipophilicity that might hamper their absorption. While
these values are acceptable for an initial structure, how-
ever, it is important to note that in terms of bioavailabil-
65ity, stability, and pharmacokinetics, most peptides are as
bad as proteins, and, in general, they do not make good
drugs unless modiﬁed in some way. It is clear that pep-
tides possess signiﬁcant limitations to be used directly as
drugs; however, on the basis of our results, these pep-
70tides seems to be adequate starting structures to develop
potential new modulators of BACE1
4. Conclusions
In this article, we report two new peptides Ac-Tyr5-
Pro6-Tyr7-Phe8-Asp9-Pro10-Leu11-NH2 and Ac-Tyr5-
75Pro6-Tyr7-Asp8-Ile9-Pro10-Leu11-NH2 possessing mod-
ulatory effects on the exosite of BACE1. This activity
might be considered moderate; however, it is enough sig-
niﬁcant as to test if these peptides can act in a synergis-
tic way jointly with the well-known INHs of the
80catalytic site of BACE1. These studies are currently
being conducted in our laboratory and will be reported
soon. Besides, the fact that these compounds act on a
different site of action to that of the INHs of the catalytic
site is in itself promising for the development of new
85INHs of this enzyme.
It is interesting to note that these peptides have been
obtained through a study of molecular modeling. Thus,
by combining MD simulations with DFT calculations,
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Figure 8. Spectra of residue interactions obtained for the com-
plex BACE1–INH 8 with respect to the inhibitor amino acids
according to the MM-GBSA method.
Notes: The x-axis denotes the residue number of INH and the
y-axis denotes the interaction energy between the inhibitor and
BACE1 upon binding.
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a simple and generally applicable procedure to evaluate
5 the binding energies of small-size peptides interacting
with the BACE1-exosite has been used here. This analy-
sis provided a clear picture of the binding interactions of
these peptides from a structural point of view. A correla-
tion between binding energies obtained from DFT calcu-
10 lations and inhibitory effect was obtained. It must be
pointed out that although the correlations obtained
between the theoretical and experimental data are signiﬁ-
cant, they are not accurate enough to properly explain
the different activities obtained for compounds possess-
15 ing similar inhibitory activity. Our results indicate that
such differences can be better explained only from a
more exhaustive electronic analysis provided by a
QTAIM analysis. Thus, the results of this study provide
a detailed topological description of the interaction net-
20 work of the small peptides in the exosite of BACE1 and
illustrate the convenience of going beyond the concept
of binding energy and their relationship with the % inhi-
bition, in order to “see” the electronic effects within the
intricate biological environment. While this kind of
25 approaches that involve the characterization of the inter-
molecular interactions by means of QTAIM was tradi-
tionally applied to the study of non covalent interactions
in small molecules in gas phase, we have shown here
that this methodology is also a very powerful tool for
30 the study of ligand–receptor complexes, providing a very
detailed description of the binding event.
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